20250163432. Composition Re (Wyvern Pharmaceuticals .)
COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID
Abstract: embodiments of the present disclosure relate to a composition that comprises a recombinant plasmid (rp) with a sequence of nucleic acids. the sequence comprise a start region, an end region and an insert positioned between the start region and the end region. the insert encodes for a sequence of micro interfering ribonucleic acid (mirna) that may be complimentary to a sequence of target messenger rna (mrna) that encodes for translation of a target biomolecule. the mirna can cause the target mrna to be degraded or inactivated, thereby causing a decrease in bioavailability of the target biomolecule because it is degraded or inactivated by the mirna, thereby decreasing the bioavailability of the target biomolecule. in some embodiments of the present disclosure, the target biomolecule is an immune checkpoint protein.
Inventor(s): Bradley G. THOMPSON, Jillian Thompson
CPC Classification: C12N15/117 (Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs)
Search for rejections for patent application number 20250163432